Industry News
Source: MedTech Dive
1 min read
Insulet names new CFO; Dexcom CEO on leave
Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.
Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.
External Source
Read the full article or press release at the original source.
Visit Original Source